Silverberg JI, Toth D, Bieber T, Alexis AF, et al. Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe
atopic dermatitis: results from the double-blind, randomized, multicentre,
placebo-controlled phase III ECZTRA 3 trial. Br J Dermatol 2020 Sep 30. doi: 10.1111/bjd.19573.
PMID: 33000503